INTRODUCTION
Reversible protein phosphorylation is a key mechanism by which environmental signals are transmitted to modify protein expression or activity in eukaryotes and prokaryotes, and therefore represents a crucial mechanism by which exogenous signals are translated into cellular responses. Eukaryotic-like Ser/Thr protein kinases (STPKs) present in bacteria are thought to play important functions in cell signaling responses as well as in essential metabolic pathways. However, understanding prokaryotic kinase biology has been hampered by the failure to identify relevant kinase substrates and subsequently characterize the phosphorylation site(s). In addition, very little is known about how phosphorylation induces structural modifications in STPK substrates, ultimately leading to changes in the biological responses in bacteria.
Corynebacterium glutamicum is a nonpathogenic Gram-positive bacterium used for industrial production of L-glutamate and other amino acids (Kimura, 2003) and represents a valuable model organism to study Corynebacteriaceae, a suborder of actinomycetes that includes Mycobacterium (Alderwick et al., 2005) . Recent studies have brought to light an unusual posttranslational regulation mechanism of the tricarboxylic (TCA) cycle in C. glutamicum (Bott, 2007) . In this organism, the 450 kDa 2-oxoglutarate dehydrogenase multienzyme complex (ODHC) catalyzes the fourth step of the TCA cycle, and regulation of ODHC activity was shown to be dependent on the OdhI (for ODHC inhibitor) phosphorylation status. In fact, the unphosphorylated form of OdhI binds with high-affinity to OdhA, the putative E1 subunit of the ODHC complex, thus inhibiting its activity, whereas OdhI phosphorylation relieves this inhibition (Niebisch et al., 2006) . Regulation of the TCA cycle by phosphorylation of the isocitrate deshydrogenase has been reported in enteric bacteria (Cozzone, 1998) . The channeling of isocitrate through the glyoxylate bypass is regulated via direct phosphorylation/dephosphorylation of the isocitrate dehydrogenase, the enzyme of the TCA cycle. However, in the present study, we characterize for the first time a novel way of controlling the TCA cycle via the 2-oxoglutarate dehydrogenase, which is not directly phosphorylated but regulated via a phosphorylation/ dephosphorylation mechanism of its specific binding regulator, OdhI.
C. glutamicum contains four STPKs named CgPknA, CgPknB, CgPknG, and CgPknL (Kalinowski et al., 2003) . Inactivation of CgpknL or CgpknG in C. glutamicum resulted in viable mutants with a normal cell morphology or growth rate. In sharp contrast, CgpknA and CgpknB were found to be essential (Fiuza et al., 2008) . Partial deletion of CgPknA or CgPknB in conditional mutants resulted in elongated cells, leading to the conclusion that these two kinases are key players in signal transduction pathways controlling corynebacterial cell shape and growth. In addition, both CgPknA and CgPknB were able to phosphorylate OdhI in vitro (Fiuza et al., 2008) , while OdhI was originally reported to be a substrate of CgPknG (Niebisch et al., 2006) .
OdhI is a 15 kDa protein, and structure prediction proposed that it is almost solely composed of a forkhead-associated (FHA) domain adjacent to an unfolded 40-residues N-terminal extension where phosphorylation occurs (Niebisch et al., 2006) . FHA domains are modular recognition domains highly specific to phosphothreonine and participating in various biological processes such as transcription, DNA repair, or protein degradation in eukaryotes . This FHA-containing protein is highly conserved in actinomycetes, suggesting that it plays an important role in the physiology of these organisms. In M. tuberculosis, the OdhI ortholog named GarA (Rv1827) shares 60% of sequence identity (82% for the FHA domain) with OdhI and has been partially characterized (Villarino et al., 2005) . Like OdhI, GarA was found to be phosphorylated by mycobacterial STPKs on an N-terminal threonine residue (Villarino et al., 2005) . Conservation of OdhI with GarA, and OdhA with its M. tuberculosis ortholog KGD (Rv1248c), leads to the hypothesis of common functions and regulatory mechanisms. Recent studies have unraveled a role for GarA in regulation of glutamate metabolism and demonstrated that both M. tuberculosis PknB and PknG were able to phosphorylate GarA (O'Hare et al., 2008) . Interestingly, M. tuberculosis PknG phosphorylates GarA at Thr21, adjacent to the residue phosphorylated by PknB (T22), and that these two phosphorylation events are mutually exclusive, supporting the occurrence of a site-specific kinase-dependent mechanism.
Because in OdhI only Thr14 (the equivalent of Thr21 in GarA) has been uncovered following phosphorylation with CgPknG, we addressed whether the adjacent residue Thr15 (the equivalent of Thr22 in GarA) could also represent a potential phosphorylation site for CgPknA or CgPknB. We therefore identified the phosphorylated site(s) of OdhI by mass spectrometry analysis following phosphorylation with either CgPknA or CgPknB. Then, to decipher the molecular mechanism responsible for the release of the inhibition on OdhA via OdhI, as well as the binding properties of the OdhI regulator after phosphorylation, we determined the solution structures of both unphosphorylated (OdhI) and phosphorylated isoforms of OdhI (pOdhI) using multidimensional nuclear magnetic resonance (NMR) techniques. Our study unraveled a new structural mechanism in which the unstructured N-terminal segment of OdhI undergoes considerable conformational changes upon phosphorylation by CgPknA or CgPknB. These changes comprise a switch of the N-terminal part of the protein in close vicinity to the FHA domain phosphopeptide binding site. Herein, we describe an original mechanism of autoinhibition of OdhI and provide a structural model describing how phosphorylation of a single Thr residue in a disordered domain affects the overall structure of a protein, ultimately conditioning the regulation of a major metabolic pathway.
RESULTS

C. glutamicum PknA/B Phosphorylate OdhI on Thr15
The OdhI/GarA family of proteins appears to be conserved in actinomycetes, and close members of this family have been found in Corynebacterium, Mycobacterium, Rhodococcus, and Streptomyces. Figure 1 presents multiple sequence alignments of OdhI proteins in several corynebacterial and mycobacterial species, including pathogenic and nonpathogenic species. C. glutamicum contains four STPKs named CgPknA, CgPknB, CgPknG, and CgPknL (Kalinowski et al., 2003) . It was previously demonstrated that a C. glutamicum strain lacking a functional CgPknG was impaired in glutamine utilization. Subsequent proteome analysis led to the identification of OdhI, a 15 kDa protein, as a substrate of CgPknG (Niebisch et al., 2006) . Moreover, CgPknG was shown to phosphorylate OdhI at position Thr14. A recent study dedicated to characterize the four corynebacterial STPKs reported that both CgPknA and CgPknB could efficiently phosphorylate OdhI in vitro in addition to CgPknG (Fiuza et al., 2008) . This protein was found to be highly homologous to the M. tuberculosis GarA protein (Villarino et al., 2005 PknG phosphorylates GarA at Thr21, adjacent to the residue phosphorylated by PknB (Thr22), and that these two phosphorylation events are mutually exclusive. These unexpected findings brought us to investigate whether CgPknA and CgPknB phosphorylate OdhI on Thr14, like CgPknG, or on Thr15. To this aim, a mass spectrometry technique was successfully developed to decipher the phosphorylation site(s). Purified recombinant OdhI was incubated with ATP in the presence of CgPknA, and subjected to mass spectrometry analysis after tryptic digestion. ProteinPilot Ò database-searching software (version 2.0, Applied Biosystems), using the Paragon method with phosphorylation emphasis, was used to detect and identify the phosphorylated peptides. The sequence coverage of the protein was 99%, and MS/MS spectrum of the triply charged ion [M+3H] 3+ at m/z 1059.8 of peptide [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] (monoisotopic mass: 3176.38 Da) unambiguously confirmed the location of the phosphate group on Thr15 as showed by observation of the ''y'' C-terminal daughter ion series (Figure 2) . Moreover, similar MS spectra were obtained when OdhI was phosphorylated with CgPknB alone, or with a mix CgPknA/CgPknB (data not shown). Overall, these results indicate that CgPknA or CgPknB phosphorylate OdhI on Thr15, which is adjacent to the residue phosphorylated by CgPknG (Thr14). This scenario is reminiscent of what was reported for GarA in M. tuberculosis (O'Hare et al., 2008) and supports the occurrence of a site-specific kinasedependent mechanism. Moreover, these results appear to suggest that corynebacterial and mycobacterial kinases share similar phosphorylation specificity toward their substrates OdhI or GarA, and could therefore be regarded as genuine functional orthologs. Figure 3 . By combining the information from the double-and triple-resonance heteronuclear experi- Unambiguous location of the phosphate group on Thr15 was showed by observation of the ''y'' C-terminal daughter ion series. Starting from the C-terminal residue, all ''y'' ions loose phosphoric acid (À98 Da) after the Thr15 phosphorylated residue.
NMR
ments, we were able to assign all the amide group resonances for the nonproline residues (9 prolines), 99.8% of the other backbone resonances (Ca, C 0 , and Ha), more than 93.8% of the Cb resonances, and 91% of the side chain protons.
In agreement with our sequence analysis, NMR experiments revealed that the N-terminal part of the unphosphorylated OdhI protein is fully disordered (Met1-Glu40). The corresponding residues give rise to the intense cross-peaks centered at 8.5 ppm in the HSQC spectrum. The rest of the molecule folds in a well-defined FHA domain. The global fold of the FHA domain, a b sandwich composed of 11 strands, is well conserved ( Figure 4A ) and similar to what has been described for the structures of the human Chk2 kinase or Ki67 FHA domains (rmsd of 1.62 Å and 1.68 Å , respectively; Li et al., 2002 Li et al., , 2004 . However, superimposition with other FHA domain structures in the free form or in complex with a phosphopeptide revealed a particular conformation of the phosphopeptide-binding surface composed of loops connecting the b strands, mainly the loops b3/b4, b4/b5, and b6/ b7. In the previously solved FHA domain containing protein structures, the phosphopeptide-binding loops adopted the same conformation in both free and complexed forms (i.e., PDB1R21 versus PDB2AFF; see Figure S1A available online). Here, loop b6/b7 in the free form is at the position that would be normally occupied by the pThr in the complexed form ( Figure S1B ). Concomitantly, the b3/b4 loop adopts a conformation incompatible with the phosphopeptide binding, whereas the position of loop b6/b7 is similar to that observed in related FHA domain structures. and 5B), indicating that its structure is globally preserved, even though some perturbations are observed on the phosphothreonine binding site. Structure calculation of the phosphorylated isoform of OdhI, pOdhI, confirms that phosphorylation induces folding of the N-terminal disordered region from residue Pro10 to Gly31 and triggers the binding of the region surrounding pThr15 to the FHA domain ( Figures 4B-4D ). More precisely, residues from Ala20 to Ser29 fold into a short a-helix, and residues from Val12 to Phe18 bind to the FHA phosphopeptide surface between loop b4/b5 and b3/b4. This positioning is consistent with the chemical shift perturbations observed on the pOdhI HSQC spectrum and with what has been observed in the previous structures of FHA domains in complex with phosphopeptides. The phosphorylation-induced a-helix is markedly amphipathic with a hydrophobic surface (Ala20, Leu22, Leu23, and Met26) facing Tyr111 and Pro116 on the b7 and the b8 FHA strands, respectively. These hydrophobic contacts, conserved in GarA, probably contribute to reinforce the interaction between the phosphorylated N-terminal peptides segment and the FHA binding site. It has been reported that the minimum motif for recognition specificity is seven residues centered on the phosphothreonine (Durocher et al., 2000) . Here, the phosphorylation results in the folding of 26 amino acids from the N-terminal, but only seven of them, centered on pThr15, are in contact with the FHA core domain according to our NMR data. The binding surface and the contacts between the phosphopeptide and its binding groove are original with an unusual dual interaction between the phosphate group and an arginine residue of loop b4/b5, Arg87. Recently a similar interaction has been described for the RNF8 FHA domain (Huen et al., 2007) . The characteristic interaction described between the FHA domain and the phosphopeptide are conserved. The phosphate group is making hydrogen bounds with the buried Ser86 and additional hydrogen-bond interactions with main-chain atoms of residues from the phosphopeptide on both sides of the phosphothreonine are present. If not directly observable in our NMR experiments, some interaction is likely to be present. For instance, Arg72 guanidinium group from the Gly-Arg dipeptide motif, located at the N-terminal side of the b3/b4 loop, is expected to be doubly H-bonded to the phosphate group. In addition, the amide side chain of the highly conserved asparagine Asn107 should make hydrogen bonds with the main-chain carbonyl oxygen of the pThr +1 residue and the peptide nitrogen of pThr +3.
Similarly, a-helix formation upon phosphorylation has been previously reported for the hNIFK phosphopeptide after binding to the Ki67 FHA domain (Byeon et al., 2005) . Multiple phosphorylations on this peptide and FHA domain binding are concomitant with the formation of a 15 aa a-helix beginning four residues after the first phosphorylated threonine. In our case, the a-helix tops the b strands b7 and b8, whereas the hNIFK peptide a-helix lies between loops b4/b5 and b10/b11 with the C-terminal part of the peptide forming an extra b strand antiparallel to b4.
The pOdhI structure clearly demonstrates an important molecular switch governed by a single phosphorylation event in a disordered domain.
DISCUSSION
In this study, the solution structure determination of OdhI isoforms revealed a major structural rearrangement in the phosphorylated isoform, characterized by a tight self-recognition binding of the phosphorylated N-terminal extension of the OdhI protein by the C-terminal FHA domain. Because phosphorylation of OdhI leads to a fully inactive protein unable to bind to OdhA, this intramolecular change accounts for an autoinhibition mechanism that shuts down the inhibition properties of OdhI (Figure 7) . Morevover, an autoinhibition mechanism similar to the one described in this study has been recently reported for the M. tuberculosis OdhI homolog GarA, using a physicochemical strategy (England et al., 2009) .
However, it remains unclear whether it is the phosphorylation and the binding of the N-terminal region that locks the FHA domain of OdhI, or if the inhibition results from the N-terminal part of OdhI becoming masked. The N-terminal sequence identity between the different species harboring OdhI/GarA orthologues is relatively low compared with the FHA domain itself (Figure 1 ). In addition, extensive sequence alignments of all the members of the family revealed that more-distant OdhI/GarA orthologs (sequence identity >60% for the FHA domain) lack (Figure 7) . Finally, an extensive analysis of OdhA/KGD phosphorylation by different STPKs would be of great interest to decipher the cross-talk networks used by the bacterium to adapt its response to external stimuli corresponding to environmental changes on the same metabolic pathway.
Our study unambiguously determined Thr15 as the unique phosphorylation site when OdhI is phosphorylated by CgPknA or CgPknB, and this was further confirmed by mass spectrometry and NMR analyses. It was previously reported that CgPknG phosphorylates OdhI on Thr14 (Niebisch et al., 2006; Schultz et al., 2007) . This strongly confirms that phosphorylation is site specific and dependent on the kinase, as already observed with the M. tuberculosis homolog GarA. In fact, similar observations have been reported for GarA, for which Thr22 was identified following treatment with PknB (which corresponds to Thr15 in OdhI, while Thr21 was the site identified following treatment with PknG (which corresponds to Thr14 in OdhI; Figure 1 ). It is noteworthy that multiple phosphorylation sites have been described in eukaryotic phosphopeptide-binding FHA domains (Byeon et al., 2005; Lee et al., 2008) . For instance, double phosphorylation of the Rad53-SCD1 peptide increases affinity to the Dun1-FHA domain by more than two orders of magnitude, compared with a single phosphorylation. However, in that case, multiple phosphorylation events occurred simultaneously in Rad53-SCD1, whereas phosphorylation by either PknA/B or PknG on GarA was mutually exclusive (O'Hare et al., 2008) .
In M. tuberculosis it has been shown that phosphorylation on both sites leads to the loss of the inhibition and binding properties (O'Hare et al., 2008) . Sequences of the loop responsible for the phosphopeptide recognition are strictly identical between GarA and OdhI ( Figure S2 ). Moreover, the N-terminal sequences are strictly conserved between OdhI and GarA around the pThr (position À4 to +6), corresponding to a larger motif than the usual residues described as essential for FHA binding (Durocher et al., 2000) . This indicates that the structural rearrangement observed on pOdhI after phosphorylation by CgPknA/B on Thr15 should be similar to the ones expected after phosphorylation on the adjacent Thr14 position while phosphorylated with CgPknG, and this in order to abolish the inhibition on OdhA. In fact, the structure of pOdhI revealed that flexibility exists within the N-terminal domain between residues Arg19 to Glu38 ( Figure 6 ). As a consequence, phosphorylation at position Thr14 could lead to a similar molecular switch. A model of pOdhI phosphorylated at position Thr14 reveals that the contact between the FHA binding site and the phosphorylated N-terminal would be possible with minor rearrangements of the phosphopeptide binding loops. With phosphorylation at position Thr14 instead of Thr15, the side chain of residue pThr +3 would be a valine (Val17) instead of a phenylalanine (Phe18), making all the hydrophobic interactions observed around this position practical. It is noteworthy that FHA domains are grouped into discrete classes primarily on the basis of pThr +3 specificity (Yaffe and Smerdon, 2004) . Similarly, a substitution at position pThr +2 from valine (Val17) to serine (Ser16), and at position pThr +1 from serine (Ser16) to threonine (Thr15), should be compatible with the binding, as the interaction between this phosphopeptide segment and the FHA binding region involves mainly backbone atoms. At position pThr +1, the threonine (Thr14) would be substituted by a glutamic acid (Glu13), but this substitution should not generate any effect as the side chain is fully exposed to the solvent and does not interact with the binding region. From our model, the Glu13 Cb and Cg methylene groups make hydrophobic contacts with Val85 side chain; therefore, substituting Glu13 at position -2 with a valine residue (Val12) might increase the binding. Despite our efforts, we never obtained an NMR sample of the pOdhI protein phosphorylated at position Thr14 by CgPknG. This is probably due to the high instability of CgPknG and the fact that this protein needs to be phosphorylated by CgPknA/B to be activated. The ability of the OdhI/GarA protein to be a common substrate of two different kinases able to phosphorylate at two adjacent positions, and thus resulting in a similar major structural modification with the loss of inhibition properties, is remarkable considering the high specificity of the FHA domain phosphopeptide binding site (Durocher et al., 2000; Yaffe and Smerdon, 2004) .
Control of enzyme activity by phosphorylation has been reported recently in actinomycetes (Bhatt et al., 2007) , but to our knowledge, the OdhA regulation by OdhI is the first reported 
Structure
Solution Structure of OdhI case of a bacterial enzyme controlled by phosphorylation via a second partner. In M. tuberculosis, for instance, there is an increasing number of processes found to be controlled by phosphorylation. Phosphorylation of the inhibitory protein (i.e., OdhI) and its target protein (i.e., OdhA) by a different set of kinases would allow bacteria to diversify and combine responses to diverse external stimuli received by different STPKs. One can also imagine that inhibitory protein (i.e., OdhI) could also recognize and therefore regulate additional targets. With a relatively restricted number of STPKs, the use of regulators like the OdhI/ GarA protein, common to multiple pathways, could represent a way for the bacteria to extend its STPK regulation pathways. Overall, our study describes for the first time a FHA domain phosphorylation-dependent regulation that leads to a functional alteration, and consequently to the inactivation, of its inhibitory properties. The FHA domain is a structural domain widespread in proteins involved in major eukaryotic cell processes. Moreover, phosphorylation of OdhI occurs in a complete disordered domain and leads to the complete loss of its properties, which is similar to eukaryotic proteins, as inhibition often involves phosphorylation of an unfolded part of the protein. This original autoinhibitory mechanism via a competitive intramolecular binding could be compared with the one observed for the eukaryotic SH2 domain protein (Kuriyan and Cowburn, 1997) . Our findings may therefore not be restricted to the exclusive prokaryotic FHA domain proteins, but may represent a more general mechanism of posttranslational regulation. The unexpected role of OdhI/GarA as a general molecular switch also emphasizes the fact that FHA domains should not be considered as solely protein-protein interaction domains but also as important activation/inhibition modules participating in prokaryotic and eukaryotic signaling.
EXPERIMENTAL PROCEDURES Expression and Purifications of the OdhI Protein
A 50 ml falcon tube containing 20 ml of L-broth (1% w/v tryptone, 0.5% w/v NaCl, 0.5% w/v yeast extract) supplemented with 100 mg/ml of ampicillin was inoculated with a single transformed bacterial colony of Escherichia coli BL21(DE3)Star, harboring a variant of His-tag fusion vector pET-15b, which was modified to contain the odhI gene from Corynebacterium glutamicum and a tobacco etch virus (TEV) protease site to replace the thrombin site coding sequence (named pET-15b-Tev). This culture was grown in an orbital incubator set at 37 C and 220 rpm overnight. From this culture, the 20 ml was used to inoculate a 2-liter flask containing 750 ml of L-broth supplemented as before with ampicillin. The culture was grown in an orbital incubator set at 37 C and 220 rpm, until the A 600 of the culture reached 0.6, and then IPTG was added at a final concentration of 0.2 mM to induce the expression of OdhI. Growth of the cultures was continued for a further 3 hr at a lower temperature of 30 C, after which the cells were harvested by centrifugation (using a Beckman Coulter Avanti J-20 XP centrifuge equipped with a 10 500 rotor and set at 7 C and 8000 rpm). The cell pellet arising from the 750 ml of culture was resuspended, on ice, in 30 ml of buffer A (50 mM Tris-HCl [pH 8.5], 150 mM NaCl) and 50 ml of 10 mg/ml lysozyme was added to aid in digestion of the cells. Cell pellets were stored at À80 C until required.
Cells were then lysed by sonication (2 s bursts for 5 min, at 60% amplitude, with a large parallel probe; Vibra CellÔ 72405 (Bioblock Scientific, Illkirch, France), after which cell debris and insoluble materials were removed by centrifugation (using a Beckman Coulter Avanti J-20 XP centrifuge equipped with a 25 50 rotor, set at 18,000 rpm, at 7 C). The supernatant arising from this step was filtered through a 0.22 mm PVDF filter (Millipore) and then loaded through a AKTA basic system into a HitrapÔ 1 ml IMAC HP column (Amersham Biosciences) equilibrated in buffer A and 4% of buffer B (50 ml of buffer A supplemented with 500 mM of imidazole). Ni 2+ -agarose affinity chromatography was then carried out at room temperature to purify the His-tagged recombinant protein. The column was washed with successive applications of buffer A and 4% of buffer B ($30 ml in total) to remove all the impurities and then buffer B was increased over 20 ml to 100%, which was collected in fractions of 0.5 ml. Fractions containing the OdhI protein were identified by SDS-PAGE, then pooled and concentrated, using a 5 K cutoff concentrator, to a final volume of 5 ml (using a Sigma Laborzentrifugen 3K15 bioblock scientific centrifuge set at 7 C, 4000 g). The concentrated protein was applied to a HiprepÔ 26/10 (Amersham Biosciences) desalting column equilibrated in buffer A, to remove the imidazole, to increase protein stability. The first two 5 ml fractions eluted corresponded to the protein and so were pooled (total volume 10 ml) and placed in a labeled 15 ml falcon tube. The solution was treated for 2 hr at room temperature with TEV protease ($1 OD of TEV for 100 OD of protein) to digest and thereby remove the N-terminal His-tag from the protein.
Finally, the 10 ml of protein was concentrated (as before) to a final volume of 2 ml and applied to a Superdex 75 26/60 (Amersham Biosciences) size exclusion column, equilibrated in buffer 20 mM Na phosphate (pH 6.2), 150 mM NaCl. This led to the removal of any remaining impurities and the tag. Again, The OdhI protein is a Krebs cycle key regulator in C. glutamicum. The unphosphorylated form of OdhI inhibits the fourth step of the cycle, and the phosphorylated form is inactive. Experimental evidence from NMR analysis unraveled a major conformational change between the two isoforms, leading to the binding of the phosphorylated N-terminal part of the protein to its own FHA domain, consequently inhibiting it, thus corresponding to an autoinhibition mechanism.
fractions containing the OdhI protein were identified by SDS-PAGE, then pooled and stored at À20 C until required.
This protocol was carried out for all nonlabeled constructs of OdhI and 15 N-labeled OdhI constructs except the cultures, which were grown in a minimum media containing 15 NH 4 Cl and 13 C6 glucose as the sole nitrogen and carbon sources.
Expression and Purification of CgPknA and CgPknB E. coli BL21(DE3)Star cells were transformed with the pGEX4T-3 vector derivatives expressing the CgPknA and CgPknB core domain proteins (Fiuza et al., 2008) . Recombinant E. coli strains harboring the pGEX4T-3 derivatives were used to inoculate 200 ml of LB medium supplemented with ampicillin and incubated at 37 C with shaking until A600 reached 0.5. Isopropyl 1-thio-b-D-galactopyranoside was then added at a final concentration of 0.5 mM, and growth was continued for an additional 3 hr period at 30 C. The cells were harvested by centrifugation at 6000 g for 10 min, washed in 10 ml of buffer A (50 mM TrisHCl [pH 7.5], 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM aprotinin), and centrifuged again under the same conditions. The cell pellet was resuspended in buffer A containing DNase I and RNase A at a final concentration of 5 g/ml each, 10 M leupeptin, and 6 M pepstatin. Cells were disrupted in a French pressure cell at 16,000 lb/in 2 (psi). The resulting suspension was centrifuged at 4 C for 30 min at 30,000 g. The supernatant was incubated for 5 hr with glutathione Sepharose 4B matrix (Pharmacia Biotech), suitable for purification of GST fusion proteins. The protein-resin complex was packed into a column for washing and elution. The column was washed with 50 ml of PBS. Protein elution was carried out with buffer B (50 mM Tris-HCl [pH 8.0], 5 mM MgCl2, 1 mM DTT) containing 15 mM glutathione. Eluted fractions were analyzed by SDS-PAGE. After dialysis against buffer C (40 mM Tris-HCl [pH 7.9], 200 mM NaCl, 0.2 mM DTT, 0.2 mM EDTA, 10% glycerol), pure fractions were pooled. All proteins were purified under the same conditions, and their identity was checked by mass spectrometry (MALDI-TOF).
Phosphorylation of OdhI by CgPknA and CgPknB
In vitro phosphorylation of each recombinant OdhI sample (5 mg) was carried out overnight at 37 C in a reaction mixture containing buffer 25 mM Tris-HCl (pH 7.0), 1 mM dithiothreitol, 5 mM MgCl2, 1 mM EDTA, and 5 mM ATP and 1 mg of kinases (CgPknA and CgPknB). The sample was then concentrated and applied to a Superdex 75 10/30 (Amersham Biosciences) size exclusion column, equilibrated in buffer 20 mM Na phosphate (pH 6.2), 150 mM NaCl. Fractions containing the OdhI protein were identified by SDS-PAGE, then pooled and stored and concentrated to a concentration of approximately 500 mM for NMR experiments.
Mass Spectrometry Analysis
Purified OdhI was subjected to in vitro phosphorylation as described. Subsequent mass spectrometry analyses were performed as previously described (Fiuza et al., 2008) . (Guntert, 2004) . Pulse sequences similar to those described (Kay et al., 1992; Wagner, 1992a, 1992b) were used to record heteronuclear 15 N{ 1 H}NOE experiments. The two experiments with and without proton saturation were acquired in an interleaved manner, FID by FID. Proton saturation was achieved by application of high-power 120 pulse spaced at 20 ms intervals for 3 s prior to the first pulse on 15 N. A relaxation delay equal to 6 s between each scan was used to obtain a complete relaxation of water magnetization and to reduce effects arising from amide proton exchange. Backbone f and c torsion angle constraints were obtained from a database search procedure on the basis of backbone ( 15 N, HN, 13 C', 13 C a , H a , 13 C b ) chemical shifts using the program TALOS (Cornilescu et al., 1999) . Hydrogen bond restraints were derived using standard criteria on the basis of the amide 1 H / 2 H exchange experiments and NOE data. When identified, the hydrogen bond was enforced using the following restraints: ranges of 1.8-2.3 Å for d (N-H,O) , and 2.7-3.3 Å for d (N,O) . The final list of restraints (from which values redundant with the covalent geometry has been eliminated) consisted of 290 intraresidues, 445 sequential, 63 medium-range (1 < i-j % 4), and 225 long-range upper-bound distance restraints, 156 backbone dihedral angle restraints (f and 4), and 60 hydrogen bond restraints. The phosphothreonine parameters were incorporated according the phosphorylated amino acid library from Craft and Legge (2005) . The 30 best structures (based on the final target penalty function values) were minimized with CNS 1.2 according the RECOORD procedure (Nederveen et al., 2005) and analyzed with PROCHECK (Laskowski et al., 1993) . The rms deviations were calculated with MOLMOL (Koradi et al., 1996) . Structural statistics are given as Supplemental Data (Table 1) . 
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